SpyBiotech receives more than $4 million to develop vaccine platform
UK-based SpyBiotech has received a grant of more than $4 million from the Bill &…
UK-based SpyBiotech has received a grant of more than $4 million from the Bill &…
CANbridge Pharmaceuticals Inc. has announced that its therapy for glioblastoma has shown a 67% survival…
Likang Life Sciences has received implied approval for the clinical trial of its personalized neoantigen-targeted…
Purple Biotech Ltd. has released new results from exploratory analyses conducted as part of a…
The Hello Tomorrow Global Summit took place in Paris last week (March 8-10), and we…
A team of scientists led by Kei-ichi Takata from the Center for Genomic Integrity (CGI)…
Inspire Biotherapeutics Inc., an emerging Canadian biotech company with a mission to create gene therapies…
Mediar Therapeutics Inc., a biotechnology company advancing a portfolio of first-in-class therapies that halt and…
Nanite Inc. has announced an investment from the Cystic Fibrosis Foundation of up to $2…
Cambrian Bio, a clinical-stage biotechnology company focused on treating and preventing chronic diseases of aging,…
Pfizer Inc. is set to acquire Seagen Inc. for $229 in cash per Seagen share…
There was good and bad news this week from Japanese company Astellas Pharma Inc. as…